New Jersey 101.5 » Johnson & Johnson http://nj1015.com New Jersey News Wed, 22 May 2013 01:24:48 +0000 en-US hourly 1 http://wordpress.org/?v=3.4.2 Feds Probe J&J on Recalled Hip Implant Marketing http://nj1015.com/feds-probe-jj-on-recalled-hip-implant-marketing/ http://nj1015.com/feds-probe-jj-on-recalled-hip-implant-marketing/#comments Sat, 23 Feb 2013 14:27:36 +0000 Townsquare News Network http://nj1015.com/?p=234020 Health care giant Johnson & Johnson says it's under investigation by federal prosecutors over the company's practices in marketing a line of hip replacements recalled two years ago because many failed and had to be replaced within five years.

Read More|Comment

]]> http://nj1015.com/feds-probe-jj-on-recalled-hip-implant-marketing/feed/ 0 Court Rules Against Johnson & Johnson in Motrin Lawsuit http://nj1015.com/court-rules-against-johnson-johnson-in-motrin-lawsuit/ http://nj1015.com/court-rules-against-johnson-johnson-in-motrin-lawsuit/#comments Wed, 13 Feb 2013 22:39:27 +0000 Townsquare News Network http://nj1015.com/?p=230346 Health care company Johnson & Johnson has been told to pay a Massachusetts teenager and her parents $63 million after she suffered a life-threatening drug reaction and lost most of her skin when she took a children's pain reliever nearly a decade ago.

Read More|Comment

]]> http://nj1015.com/court-rules-against-johnson-johnson-in-motrin-lawsuit/feed/ 0 Motrin pills (Flickr user grafixtek) FDA Allows Generic Version of Scarce J&J Cancer Drug http://nj1015.com/fda-allows-generic-version-of-scarce-jj-cancer-drug/ http://nj1015.com/fda-allows-generic-version-of-scarce-jj-cancer-drug/#comments Tue, 05 Feb 2013 04:36:10 +0000 Townsquare News Network http://nj1015.com/?p=226161 Federal regulators say approval of the first generic version of cancer drug Doxil will help resolve a lingering shortage triggered by manufacturing deficiencies.

Read More|Comment

]]> http://nj1015.com/fda-allows-generic-version-of-scarce-jj-cancer-drug/feed/ 0 Doxil label (WKYC-TV) FDA Panel Backs Novel J&J Diabetes Pill http://nj1015.com/fda-panel-backs-novel-jj-diabetes-pill/ http://nj1015.com/fda-panel-backs-novel-jj-diabetes-pill/#comments Thu, 10 Jan 2013 22:30:49 +0000 Townsquare News Network http://nj1015.com/?p=215131 A panel of federal health experts has ruled that an experimental diabetes drug from Johnson & Johnson is safe and effective, though lingering safety questions must be tracked in long-term studies.

Read More|Comment

]]> http://nj1015.com/fda-panel-backs-novel-jj-diabetes-pill/feed/ 0 Does Johnson & Johnson Diabetes Drug Pose Heart Risk? http://nj1015.com/does-johnson-johnson-diabetes-drug-pose-heart-risk/ http://nj1015.com/does-johnson-johnson-diabetes-drug-pose-heart-risk/#comments Tue, 08 Jan 2013 23:15:04 +0000 Townsquare News Network http://nj1015.com/?p=213997 Federal drug reviewers think Johnson & Johnson's experimental diabetes drug might bring heart risks because it raised cholesterol levels in patient testing.

Read More|Comment

]]> http://nj1015.com/does-johnson-johnson-diabetes-drug-pose-heart-risk/feed/ 0 J&J, Pfizer End Development of Alzheimer's Drug http://nj1015.com/jj-pfizer-end-development-of-alzheimers-drug/ http://nj1015.com/jj-pfizer-end-development-of-alzheimers-drug/#comments Tue, 07 Aug 2012 02:18:29 +0000 Townsquare News Network http://nj1015.com/?p=147437 Pfizer Inc. and Johnson & Johnson say they are ending development of a once-promising drug designed to trea Alzheimer's disease after the treatment failed in two late-stage clinical trials.

Read More|Comment

]]> http://nj1015.com/jj-pfizer-end-development-of-alzheimers-drug/feed/ 0 Cristina Arias, Getty Images J&J to Pay $2.2-Billion in Risperdal Settlement: Report http://nj1015.com/jj-to-pay-2-2-billion-in-risperdal-settlement-report/ http://nj1015.com/jj-to-pay-2-2-billion-in-risperdal-settlement-report/#comments Fri, 20 Jul 2012 02:40:27 +0000 Townsquare News Network http://nj1015.com/?p=138634 A published report says Johnson & Johnson has agreed to pay as much as $2.2 billion to resolve an investigation into its marketing of the anti-psychotic drug Risperdal.

Read More|Comment

]]> http://nj1015.com/jj-to-pay-2-2-billion-in-risperdal-settlement-report/feed/ 0 Cristina Arias, Getty Images J&J, Shareholders Reach Tentative Deal in Lawsuit http://nj1015.com/jj-shareholders-reach-tentative-deal-in-lawsuit/ http://nj1015.com/jj-shareholders-reach-tentative-deal-in-lawsuit/#comments Thu, 12 Jul 2012 22:02:17 +0000 Townsquare News Network http://nj1015.com/?p=134822 Lawyers for Johnson & Johnson shareholders suing management for not fixing serious problems for years-- from shoddy manufacturing to paying kickbacks to boost sales -- have reached a tentative settlement with the health care giant.

Read More|Comment

]]> http://nj1015.com/jj-shareholders-reach-tentative-deal-in-lawsuit/feed/ 0 Cristina Arias, Getty Images Johnson & Johnson Seeks Approval for First Drug Against Tuberculosis http://nj1015.com/johnson-johnson-seeks-approval-for-first-drug-against-tuberculosis/ http://nj1015.com/johnson-johnson-seeks-approval-for-first-drug-against-tuberculosis/#comments Mon, 02 Jul 2012 16:22:32 +0000 Townsquare News Network http://nj1015.com/?p=129848 Johnson & Johnson is seeking U.S. approval for the first new type of medicine to fight deadly tuberculosis in more than four decades.

Read More|Comment

]]> http://nj1015.com/johnson-johnson-seeks-approval-for-first-drug-against-tuberculosis/feed/ 0 Cristina Arias, Getty Images FDA Denies Expanded Approval of J&J Blood Thinner http://nj1015.com/fda-denies-expanded-approval-of-jj-blood-thinner/ http://nj1015.com/fda-denies-expanded-approval-of-jj-blood-thinner/#comments Fri, 22 Jun 2012 03:55:17 +0000 Townsquare News Network http://nj1015.com/?p=124552 Federal regulators have denied Johnson & Johnson's request to expand approval of its blood thinner Xarelto for a new use to prevent life-threatening blood clots in high-risk patients.

Read More|Comment

]]> http://nj1015.com/fda-denies-expanded-approval-of-jj-blood-thinner/feed/ 0